Print

Seattle Genetics, Inc. (SGEN) Reports Second Quarter 2012 Financial Results  
8/9/2012 10:17:07 AM

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today reported financial results for the second quarter ended June 30, 2012. The company also highlighted progress with ADCETRIS (brentuximab vedotin) commercialization activities, ongoing and planned clinical trials and upcoming milestones.
//-->